PatientsVille.com Logo

PatientsVille

Celluvisc Side Effects

Common Celluvisc Side Effects


The most commonly reported Celluvisc side effects (click to view or check a box to report):

Eye Discharge (2)
Periorbital Haematoma (1)
Pain (1)
Oral Herpes (1)
Respiratory Tract Infection (1)
Swollen Tongue (1)
Jaundice (1)
Lobar Pneumonia (1)
Tumour Necrosis (1)
Oral Candidiasis (1)
Ocular Icterus (1)
Mediastinitis (1)
Madarosis (1)
Lung Adenocarcinoma Metastatic (1)
Mental Disorder (1)
Neoplasm Progression (1)
Ocular Hyperaemia (1)
Nightmare (1)
Nervousness (1)
Off Label Use (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Celluvisc Side Effects Reported to FDA

The following Celluvisc reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Celluvisc on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Ocular Icterus, Jaundice
This is a report of a 81-year-old female patient (weight: NA) from , suffering from the following symptoms/conditions: NA, who was treated with Celluvisc (carmellose) (dosage: NA, start time: Mar 02, 2012), combined with:
  • Omeprazole
  • Sodium Bicarbonate In Plastic Container
  • Terbinafine Hydrochloride
and developed a serious reaction and side effect(s). The consumer presented with:
  • Ocular Icterus
  • Jaundice
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Celluvisc (carmellose) treatment in female patients, resulting in ocular icterus side effect.

Condition Aggravated, Corneal Opacity, Diffuse Lamellar Keratitis
This report suggests a potential Celluvisc Condition Aggravated, Corneal Opacity, Diffuse Lamellar Keratitis side effect(s) that can have serious consequences. A 38-year-old patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: postoperative care and used Celluvisc (dosage: Unk) starting Dec 08, 2011. Soon after starting Celluvisc the patient began experiencing various side effects, including:
  • Condition Aggravated
  • Corneal Opacity
  • Diffuse Lamellar Keratitis
Drugs used concurrently:
  • Acuvail (Unk)
  • Pred Forte (Unk)
  • Zymaxid (Unk)
Although Celluvisc demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as condition aggravated, may still occur.

Off Label Use, Haemoglobin Decreased, Tumour Necrosis, Neoplasm Progression, Haemoptysis, Mediastinitis, Lung Adenocarcinoma Metastatic
This Off Label Use, Haemoglobin Decreased, Tumour Necrosis, Neoplasm Progression, Haemoptysis, Mediastinitis, Lung Adenocarcinoma Metastatic problem was reported by a physician from FRANCE. A 51-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Apr 22, 2011 this consumer started treatment with Celluvisc (carmellose Sodium) (dosage: NA). The following drugs were being taken at the same time:
  • Augmentin (amoxicillin Sodium, Clavulanate Potassium)
  • Spasfon (phloroglucinol, Trimethylphloroglucinol)
  • Seretide (fluticasone Propionate, Salmeterol Xinafoate)
  • Protifar (minerals Nos, Carbohydrates Nos, Protens Nos, Lipids Nos)
  • Innohep (10000 Iu,subcutaneous)
  • Nexium
  • Amoxicillin
  • Tolexine (doxycycline)
When commencing Celluvisc (carmellose Sodium), the patient experienced the following unwanted symptoms/side effects:
  • Off Label Use
  • Haemoglobin Decreased
  • Tumour Necrosis
  • Neoplasm Progression
  • Haemoptysis
  • Mediastinitis
  • Lung Adenocarcinoma Metastatic
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as off label use, may become evident only after a product is in use by the general population.

Ocular Hyperaemia, Erythema Of Eyelid
This is a report of a 71-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: dry eye,growth of eyelashes and was treated with Celluvisc (dosage: NA) starting Jan 16, 2011. Concurrently used drugs:
  • Latisse (1 Gtt, Qhs)
Soon after that, the consumer experienced the following side effects:
  • Ocular Hyperaemia
  • Erythema Of Eyelid
This opens a possibility that Celluvisc treatment could cause the above reactions, including ocular hyperaemia, and some female subjects may be more susceptible.


Hypersensitivity
A 11-year-old female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: NA started Celluvisc treatment (dosage: Unk) on Aug 18, 2011. Soon after starting Celluvisc treatment, the subject experienced various side effects, including:
  • Hypersensitivity
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Celluvisc.

Hyperhidrosis, Nightmare, Mental Disorder, Eye Disorder, Madarosis, Eye Discharge, Eyelid Disorder, Eye Swelling, Periorbital Haematoma
A 48-year-old female patient from UNITED KINGDOM (weight: NA) experienced symptoms, such as: dry eye and was treated with Celluvisca?(dosage: Unk). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Hyperhidrosis
  • Nightmare
  • Mental Disorder
  • Eye Disorder
  • Madarosis
  • Eye Discharge
  • Eyelid Disorder
  • Eye Swelling
  • Periorbital Haematoma
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Celluvisca? efficacy:
  • Blinkaway


Respiratory Tract Infection, International Normalised Ratio Increased, Anaemia, Oral Herpes, Oral Candidiasis, Lobar Pneumonia
In this report, Celluvisc (carmellose Sodium) was administered for the following condition: NA.A 75-year-old female consumer from ITALY (weight: NA) started Celluvisc (carmellose Sodium) treatment (dosage: NA) on Oct 22, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Respiratory Tract Infection
  • International Normalised Ratio Increased
  • Anaemia
  • Oral Herpes
  • Oral Candidiasis
  • Lobar Pneumonia
A possible interaction with other drugs could have contributed to this reaction:
  • Movicol (movicol /01749801/)
  • Cedax (400 Mg;cap;po;qd)
  • Sintrom (4 Mg;tab;po;qw)
  • Omeprazole (omeprazole /00661201/)
  • Melatonin (melatonin)
  • Isoptin (verapamil Hydrochloride /00014302/)
  • Tramadol Hydrochloride
  • Salagen (pilocarpine Hydrochloride /00043503/)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Celluvisc (carmellose Sodium) treatment could be related to the listed above side effect(s).

Eye Discharge
This is a report of the following Celluvisc side effect(s):
  • Eye Discharge
A 54-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: dry eye and received a treatment with Celluvisc (dosage: NA) starting: Jul 01, 2010.The following concurrently used drugs could have generated interactions:
  • Restasis (1 Gtt, Bid)
  • Refresh Tears
This report suggests that a Celluvisc treatment could be associated with the listed above side effect(s).

Dyspnoea, Insomnia, Nervousness, Swollen Tongue
This Celluvisc report was submitted by a 37-year-old male consumer from SOUTH AFRICA (weight: NA). The patient was diagnosed with: NA and Celluvisc was administered (dosage: Unk) starting: NS. The consumer developed a set of symptoms:
  • Dyspnoea
  • Insomnia
  • Nervousness
  • Swollen Tongue
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Celluvisc treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Application Site Anaesthesia, Application Site Irritation, Injury, Pain
This is a report of a possible correlation between Celluvisc use and the following symptoms/side effect(s):
  • Application Site Anaesthesia
  • Application Site Irritation
  • Injury
  • Pain
which could contribute to an assessment of Celluvisc risk profile.A 46-year-old male consumer from UNITED STATES (weight: NA) was suffering from dry eye and was treated with Celluvisc (dosage: 1-2 Drops Per Eye) starting Dec 01, 2001.Other concurrent medications: NA.The patient was hospitalized.

Vision Blurred
A 46-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: dry eye and after a treatment with Celluvisc (dosage: 1 Vial 1 Ophthalmic) experienced the following side effect(s):
  • Vision Blurred
The treatment was started on Aug 23, 2006. Celluvisc was used in combination with the following drugs: NA.This report could alert potential Celluvisc consumers.



Top 10 Celluvisc Side Effects for Men

Men Side EffectsReports
Application Site Anaesthesia 1
Application Site Irritation 1
Dyspnoea 1
Injury 1
Insomnia 1
Nervousness 1
Pain 1
Swollen Tongue 1

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Celluvisc Side Effects

    Did You Have a Celluvisc Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Celluvisc for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Celluvisc Safety Alerts, Active Ingredients, Usage Information

    NDC0023-4554
    TypeHUMAN OTC DRUG
    Proprietary NameREFRESH CELLUVISC
    Namecarboxymethylcellulose sodium
    Dosage FormGEL
    RouteOPHTHALMIC
    On market since19891004
    LabelerAllergan, Inc.
    Active Ingredient(s)CARBOXYMETHYLCELLULOSE SODIUM
    Strength(s)10
    Unit(s)mg/mL
    Pharma Class

    More About Celluvisc

    Side Effects reported to FDA: 11

    Celluvisc safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 1

    Latest Celluvisc clinical trials

    Celluvisc Reviews

    No reviews, be a first to report a side effect via side effect reporting form